ArticleExploration (Beijing, China)2022

Nucleus-specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy.

Zixian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.